KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Working Capital Changes (2016 - 2025)

Emergent BioSolutions' Other Working Capital Changes history spans 16 years, with the latest figure at $15.4 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 87.78% year-over-year to $15.4 million; the TTM value through Dec 2025 reached -$11.7 million, up 42.36%, while the annual FY2025 figure was -$11.7 million, 42.36% up from the prior year.
  • Other Working Capital Changes reached $15.4 million in Q4 2025 per EBS's latest filing, up from $2.1 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $400.0 million in Q3 2021 to a low of -$126.8 million in Q3 2024.
  • Average Other Working Capital Changes over 5 years is $13.3 million, with a median of -$50000.0 recorded in 2024.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 2973.17% in 2024, then crashed 14550.0% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$86.6 million in 2021, then soared by 71.13% to -$25.0 million in 2022, then skyrocketed by 116.4% to $4.1 million in 2023, then surged by 2973.17% to $126.0 million in 2024, then tumbled by 87.78% to $15.4 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Other Working Capital Changes are $15.4 million (Q4 2025), $2.1 million (Q3 2025), and -$28.9 million (Q2 2025).